Loading...
Explore More at wakehealth.edu

Clinical and Translational Science Institute

Keywords
Last Name

Robert J. Applegate, M.D.

TitleProfessor
InstitutionWake Forest School of Medicine
DepartmentInt Med-Cardiovascular Med
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gilbert ON, Choi CH, Franzil JL, Caughey M, Qureshi W, Stacey RB, Pu M, Applegate RJ, Gandhi SK, Zhao DXM. Comparison of paravalvular aortic leak characteristics in the Medtronic CoreValve versus Edwards Sapien Valve: Paravalvular aortic leak characteristics. Catheter Cardiovasc Interv. 2018 Nov 01; 92(5):972-980. PMID: 29726601.
      View in: PubMed
    2. Alvarez M, Applegate RJ. Early and Late Bioresorbable Vascular Scaffold Thrombosis: Size Matters. JACC Cardiovasc Interv. 2017 12 11; 10(23):2372-2374. PMID: 29217000.
      View in: PubMed
    3. Drafts BC, Choi CH, Sangal K, Cammarata MW, Applegate RJ, Gandhi SK, Kincaid EH, Kon N, Zhao DX. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach. Catheter Cardiovasc Interv. 2018 06; 91(7):1354-1362. PMID: 29024382.
      View in: PubMed
    4. Conrotto F, D'Ascenzo F, Cerrato E, Fernández-Ortiz A, Gonzalo N, Macaya F, Tamburino C, Barbanti M, van Lavieren M, Piek JJ, Applegate RJ, Latib A, Spinnler MT, Marzullo R, Iannaccone M, Pavani M, Crimi G, Fattori R, Chinaglia A, Presbitero P, Varbella F, Gaita F, Escaned J. Safety and efficacy of drug eluting stents in patients with spontaneous coronary artery dissection. Int J Cardiol. 2017 Jul 01; 238:105-109. PMID: 28318654.
      View in: PubMed
    5. Applegate RJ. Percutaneous Coronary Intervention for Multivessel Disease and ST-Segment Elevation Myocardial Infarction: When, Not Whether. JACC Cardiovasc Interv. 2016 09 12; 9(17):1777-9. PMID: 27609251.
      View in: PubMed
    6. Applegate RJ. Walking the Tightrope Between Suppressing Ischemia and Minimizing Bleeding. JACC Cardiovasc Interv. 2016 07 25; 9(14):1484-6. PMID: 27478116.
      View in: PubMed
    7. Applegate RJ. Unraveling the Biological Effects of Drug-Eluting Stents. JACC Cardiovasc Interv. 2016 Feb 08; 9(3):292-294. PMID: 26847121.
      View in: PubMed
    8. Hermiller JB, Applegate RJ, Baird C, Butler MM, Rutledge D, Wang J, Kakarala K, Krucoff MW, Sudhir K. Clinical outcomes in real-world patients with bifurcation lesions receiving Xience V everolimus-eluting stents: Four-year results from the Xience V USA study. Catheter Cardiovasc Interv. 2016 Jul; 88(1):62-70. PMID: 26399687.
      View in: PubMed
    9. Sharma R, Applegate RJ. Allen's Testing Prior to Transradial Cardiac Catheterization: State of the Arch. J Invasive Cardiol. 2015 Sep; 27(9):421-2. PMID: 26332876.
      View in: PubMed
    10. Applegate RJ. Retrograde Percutaneous Coronary Intervention for Chronic Total Occlusion: Going Backward to Go Forward. J Am Coll Cardiol. 2015 Jun 09; 65(22):2401-3. PMID: 26046733.
      View in: PubMed
    11. Kern MJ, Applegate RJ, Bell M, Brilakis ES, Butman SM, Bach RG, Kaul P, Klein LW, Krucoff MW, Moore JA, Price MJ, Rao SV, Stone GW, Uretsky BF. Conversations in cardiology: bridging antiplatelet therapy before surgery. Catheter Cardiovasc Interv. 2014 Apr 01; 83(5):748-52. PMID: 24395180.
      View in: PubMed
    12. Applegate RJ. Radial access for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: time for a paradigm shift? J Am Coll Cardiol. 2014 Mar 18; 63(10):973-5. PMID: 24269364.
      View in: PubMed
    13. Whitbeck MG, Applegate RJ. Second generation drug-eluting stents: a review of the everolimus-eluting platform. Clin Med Insights Cardiol. 2013; 7:115-26. PMID: 23926441.
      View in: PubMed
    14. Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W. Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E375-84. PMID: 23074085.
      View in: PubMed
    15. Forrest JK, Lansky AJ, Meller SM, Hou L, Sood P, Applegate RJ, Wang JC, Skelding KA, Shah A, Kereiakes DJ, Sudhir K, Cristea E, Yaqub M, Stone GW. Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 years. Am J Cardiol. 2013 Jun 01; 111(11):1580-6. PMID: 23499270.
      View in: PubMed
    16. Applegate RJ. Vascular closure device failure: we are getting better but not there yet. JACC Cardiovasc Interv. 2012 Aug; 5(8):845-7. PMID: 22917456.
      View in: PubMed
    17. Jollis JG, Al-Khalidi HR, Monk L, Roettig ML, Garvey JL, Aluko AO, Wilson BH, Applegate RJ, Mears G, Corbett CC, Granger CB. Expansion of a regional ST-segment-elevation myocardial infarction system to an entire state. Circulation. 2012 Jul 10; 126(2):189-95. PMID: 22665718.
      View in: PubMed
    18. Hermiller JB, Sudhir K, Applegate RJ, Rizvi A, Wang J, Gordon PC, Yaqub M, Cao S, Ferguson JM, Smith RS, Sood P, Stone GW. Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trials. EuroIntervention. 2012 May 15; 8(1):87-93. PMID: 22580252.
      View in: PubMed
    19. Lansky AJ, Brar SS, Yaqub M, Sood P, Applegate RJ, Lazar D, Jankovic I, Hermiller JB, Koo K, Sudhir K, Stone GW. Impact of routine angiographic follow-up after percutaneous coronary intervention with drug-eluting stents in the SPIRIT III randomized trial at three years. Am J Cardiol. 2012 Jul 01; 110(1):21-9. PMID: 22464212.
      View in: PubMed
    20. Pervaiz MH, Sood P, Sudhir K, Hermiller JB, Hou L, Hattori K, Su X, Cao S, Wang J, Applegate RJ, Kereiakes DJ, Yaqub M, Stone GW, Cutlip DE. Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions. Circ Cardiovasc Interv. 2012 Apr; 5(2):150-6. PMID: 22438430.
      View in: PubMed
    21. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, ten Berg JM, Brodie BR, Urban P, Jensen LO, Sardi G, Waksman R, Lasala JM, Schulz S, Stone GW, Airoldi F, Colombo A, Lemesle G, Applegate RJ, Buonamici P, Kirtane AJ, Undas A, Sheiban I, Gaita F, Sangiorgi G, Modena MG, Frati G, Biondi-Zoccai G. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol. 2013 Jul 31; 167(2):575-84. PMID: 22360945.
      View in: PubMed
    22. Applegate RJ, Hermiller JB, Gordon PC, Yaqub M, Sood P, Su X, Cao S, Sudhir K, Stone GW. Predictors of early and late outcomes after everolimus and paclitaxel-eluting coronary stents. EuroIntervention. 2012 Jan; 7(9):1030-42. PMID: 22207228.
      View in: PubMed
    23. Turner S, Sacrinty M, Manogue M, Little W, Gandhi S, Kutcher M, Santos R, Applegate R. Transitioning to the radial artery as the preferred access site for cardiac catheterization: an academic medical center experience. Catheter Cardiovasc Interv. 2012 Aug 01; 80(2):247-57. PMID: 22162430.
      View in: PubMed
    24. Applegate RJ. Long-term impact of periprocedural bleeding when does it end? J Am Coll Cardiol. 2011 Oct 18; 58(17):1757-9. PMID: 21996386.
      View in: PubMed
    25. Freilich MI, Gossman DE, Applegate RJ, Werns SW, Gips SJ, Turi ZG. The "bladder sign"--an important early marker of retroperitoneal hemorrhage. Catheter Cardiovasc Interv. 2012 Jan 01; 79(1):158-65. PMID: 21542107.
      View in: PubMed
    26. Hermiller JB, Nikolsky E, Lansky AJ, Applegate RJ, Sanz M, Yaqub M, Sood P, Cao S, Sudhir K, Stone GW. Clinical and angiographic outcomes of elderly patients treated with everolimus-eluting versus paclitaxel-eluting stents: three-year results from the SPIRIT III randomised trial. EuroIntervention. 2011 Jul; 7(3):307-13. PMID: 21729832.
      View in: PubMed
    27. Dauerman HL, Rao SV, Resnic FS, Applegate RJ. Bleeding avoidance strategies. Consensus and controversy. J Am Coll Cardiol. 2011 Jun 28; 58(1):1-10. PMID: 21700085.
      View in: PubMed
    28. Schafer PE, Sacrinty MT, Cohen DJ, Kutcher MA, Gandhi SK, Santos RM, Little WC, Applegate RJ. Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice. Circ Cardiovasc Qual Outcomes. 2011 Jul; 4(4):408-15. PMID: 21693724.
      View in: PubMed
    29. Applegate RJ. Optimal therapy for ST-segment elevation myocardial infarction: the role of residual thrombus. J Am Coll Cardiol. 2011 May 10; 57(19):1874-6. PMID: 21545943.
      View in: PubMed
    30. Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, Maddux JT, Cutlip DE, Simonton CA, Sood P, Kereiakes DJ. Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol. 2011 Jun 28; 58(1):19-25. PMID: 21514084.
      View in: PubMed
    31. Applegate RJ. Toward better stratification of patients with left main disease: value of clinical and angiographic-derived risk scores. JACC Cardiovasc Interv. 2011 Mar; 4(3):298-9. PMID: 21435607.
      View in: PubMed
    32. Humphrey HL, Applegate RJ. Risk scoring systems for PCI: does one size fit all? J Invasive Cardiol. 2011 Feb; 23(2):70-1. PMID: 21297203.
      View in: PubMed
    33. Ng VG, Lansky AJ, Hermiller JB, Farhat N, Applegate RJ, Yaqub M, Sood P, Su X, Simonton CA, Sudhir K, Stone GW. Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial). Am J Cardiol. 2011 Mar 15; 107(6):841-8. PMID: 21255760.
      View in: PubMed
    34. Applegate RJ, Yaqub M, Hermiller JB, Sood P, Yu S, Doostzadeh J, Williams JE, Farhat N, Caputo R, Lansky AJ, Cutlip DE, Sudhir K, Stone GW. Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial). Am J Cardiol. 2011 Mar 15; 107(6):833-40. PMID: 21247538.
      View in: PubMed
    35. Kereiakes DJ, Cutlip DE, Applegate RJ, Wang J, Yaqub M, Sood P, Su X, Su G, Farhat N, Rizvi A, Simonton CA, Sudhir K, Stone GW. Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System). J Am Coll Cardiol. 2010 Dec 14; 56(25):2084-9. PMID: 21144968.
      View in: PubMed
    36. Applegate R, Hermiller J, Williams J, Gordon P, Doostzadeh J, Cao S, Su X, Sudhir K, Lansky A, Simonton C, Stone G. Evaluation of the effects of everolimus-eluting and paclitaxel-eluting stents on target lesions with jailed side branches: 2-year results from the SPIRIT III randomized trial. Catheter Cardiovasc Interv. 2010 Nov 01; 76(5):644-51. PMID: 20506356.
      View in: PubMed
    37. Applegate RJ, Turi Z, Sachdev N, Ahmed A, Szyniszewski A, Foster M, Pratsos A, Shapiro T, Yakubov S, Shavelle D. The Angio-Seal Evolution registry: outcomes of a novel automated Angio-Seal vascular closure device. J Invasive Cardiol. 2010 Sep; 22(9):420-6. PMID: 20814049.
      View in: PubMed
    38. Lambert ND, Applegate RJ. The comparative safety of bare-metal and drug-eluting intracoronary stents. Expert Rev Med Devices. 2010 Sep; 7(5):611-24. PMID: 20822385.
      View in: PubMed
    39. Applegate RJ, Hermiller JJ, Sanz M, Doostzadeh J, Pierson W, Su X, Lansky AJ, Sudhir K, Stone GW. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients with two treated vessels: 2-year results from the SPIRIT III randomised trial. EuroIntervention. 2010 Sep; 6(4):437-46. PMID: 20884430.
      View in: PubMed
    40. Applegate RJ. Unintended consequences of femoral artery closure devices. J Invasive Cardiol. 2010 Aug; 22(8):358-9. PMID: 20679670.
      View in: PubMed
    41. Applegate RJ. Fractional flow reserve-guided stent therapy for multivessel disease: taking a closer look. J Am Coll Cardiol. 2010 Jun 22; 55(25):2822-4. PMID: 20579538.
      View in: PubMed
    42. Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. J Invasive Cardiol. 2010 Jun; 22(6):266-70. PMID: 20516505.
      View in: PubMed
    43. Gordon PC, Applegate RJ, Hermiller JB, Weinsier SB, Doostzadeh J, Cao S, Sudhir K, Lansky AJ, Stone GW. Clinical and angiographic outcomes with an everolimus-eluting stent in large coronary arteries: the SPIRIT III 4.0 mm registry. Catheter Cardiovasc Interv. 2010 Feb 01; 75(2):179-86. PMID: 19877267.
      View in: PubMed
    44. Applegate RJ. Primary PCI for STEMI - Pushing the limits. J Invasive Cardiol. 2009 Dec; 21(12):645-6. PMID: 19966368.
      View in: PubMed
    45. Applegate R, Sacrinty M, Little W, Gandhi S, Kutcher M, Santos R. Prognostic implications of vascular complications following PCI. Catheter Cardiovasc Interv. 2009 Jul 01; 74(1):64-73. PMID: 19202551.
      View in: PubMed
    46. Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction. Am Heart J. 2009 Apr; 157(4):688-94. PMID: 19332197.
      View in: PubMed
    47. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. 3-year comparison of drug-eluting versus bare-metal stents. JACC Cardiovasc Interv. 2009 Mar; 2(3):231-9. PMID: 19463431.
      View in: PubMed
    48. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Circ Cardiovasc Interv. 2009 Feb; 2(1):35-42. PMID: 20031691.
      View in: PubMed
    49. Applegate RJ, Davis JM, Leonard JC. Treatment of ostial lesions using the Szabo technique: a case series. Catheter Cardiovasc Interv. 2008 Nov 15; 72(6):823-8. PMID: 18798240.
      View in: PubMed
    50. Applegate RJ, Sacrinty MT, Little WC, Santos RM, Gandhi SK, Kutcher MA. Incidence of coronary stent thrombosis based on academic research consortium definitions. Am J Cardiol. 2008 Sep 15; 102(6):683-8. PMID: 18773988.
      View in: PubMed
    51. Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W. Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis. Catheter Cardiovasc Interv. 2008 Jul 01; 72(1):7-12. PMID: 18412239.
      View in: PubMed
    52. Applegate RJ, Sacrinty MT, Kutcher MA, Kahl FR, Gandhi SK, Santos RM, Little WC. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. JACC Cardiovasc Interv. 2008 Jun; 1(3):317-26. PMID: 19463320.
      View in: PubMed
    53. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting. Am Heart J. 2008 Aug; 156(2):234-40. PMID: 18657651.
      View in: PubMed
    54. Applegate RJ, Graham SH, Gandhi SK, Kutcher MA, Sacrinty MT, Santos RM, Little WC. Culprit vessel PCI versus traditional cath and PCI for STEMI. J Invasive Cardiol. 2008 May; 20(5):224-8. PMID: 18460706.
      View in: PubMed
    55. Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC. ABO blood types: influence on infarct size, procedural characteristics and prognosis. Thromb Res. 2008; 123(2):200-5. PMID: 18378281.
      View in: PubMed
    56. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2008 Feb 12; 51(6):607-14. PMID: 18261678.
      View in: PubMed
    57. Jollis JG, Roettig ML, Aluko AO, Anstrom KJ, Applegate RJ, Babb JD, Berger PB, Bohle DJ, Fletcher SM, Garvey JL, Hathaway WR, Hoekstra JW, Kelly RV, Maddox WT, Shiber JR, Valeri FS, Watling BA, Wilson BH, Granger CB. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA. 2007 Nov 28; 298(20):2371-80. PMID: 17982184.
      View in: PubMed
    58. Dauerman HL, Applegate RJ, Cohen DJ. Vascular closure devices: the second decade. J Am Coll Cardiol. 2007 Oct 23; 50(17):1617-26. PMID: 17950141.
      View in: PubMed
    59. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Kahl FR, Santos RM, Little WC. Vascular complications in women after catheterization and percutaneous coronary intervention 1998-2005. J Invasive Cardiol. 2007 Sep; 19(9):369-74. PMID: 17827504.
      View in: PubMed
    60. McKee SA, Applegate RJ, Hoyle JR, Sacrinty MT, Kutcher MA, Sane DC. Cocaine use is associated with an increased risk of stent thrombosis after percutaneous coronary intervention. Am Heart J. 2007 Jul; 154(1):159-64. PMID: 17584570.
      View in: PubMed
    61. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Kahl FR, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention using thrombin hemostatic patch-facilitated manual compression. J Invasive Cardiol. 2007 Apr; 19(4):164-70. PMID: 17404401.
      View in: PubMed
    62. Applegate RJ. Bivalirudin and DES: a PCI strategy that pays. J Invasive Cardiol. 2007 Feb; 19(2):69-70. PMID: 17268040.
      View in: PubMed
    63. Applegate RJ, Grabarczyk MA, Sane DC, Sacrinty MT, Goodin JE, Statonk GS, Baki TT, Gandhi SK, Kutcher MA, Little WC. PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients. J Invasive Cardiol. 2006 Dec; 18(12):604-13. PMID: 17197712.
      View in: PubMed
    64. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol. 2007 Feb 01; 99(3):333-8. PMID: 17261393.
      View in: PubMed
    65. Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial. J Am Coll Cardiol. 2006 Dec 19; 48(12):2440-7. PMID: 17174180.
      View in: PubMed
    66. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC. Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998-2003. Catheter Cardiovasc Interv. 2006 Apr; 67(4):556-62. PMID: 16532497.
      View in: PubMed
    67. Applegate RJ, Draughn T, Yarbrough WD, Little WC. Restenosis of a sirolimus drug-eluting stent: aorto-ostial involvement of the proximal right coronary artery. Catheter Cardiovasc Interv. 2006 Mar; 67(3):391-5. PMID: 16475190.
      View in: PubMed
    68. Applegate RJ, Sacrinty M, Kutcher MA, Gandhi SK, Baki TT, Santos RM, Little WC. Vascular complications with newer generations of angioseal vascular closure devices. J Interv Cardiol. 2006 Feb; 19(1):67-74. PMID: 16483343.
      View in: PubMed
    69. Applegate RJ, Upadhya B, Little WC, Xenakis M, Gandhi SK, Baki TT, Kahl FR, Kutcher MA. Late outcomes after intervention of vein grafts in diabetics with abciximab use. Int J Cardiol. 2006 Jul 28; 111(1):136-41. PMID: 16226815.
      View in: PubMed
    70. Upadhya B, Applegate RJ, Sane DC, Deliargyris EN, Kutcher MA, Gandhi SK, Baki TT, Call JT, Little WC. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol. 2005 Aug 15; 96(4):515-8. PMID: 16098303.
      View in: PubMed
    71. Applegate RJ, Draughn T, Davis B. Treatment of complex LAD-diagonal bifurcation disease using paclitaxel drug-eluting stents. J Invasive Cardiol. 2005 Jul; 17(7):390-2. PMID: 16003029.
      View in: PubMed
    72. Deliargyris EN, Upadhya B, Applegate RJ, Kontos JL, Kutcher MA, Riesmeyer JS, Sane DC. Safety of abciximab administration during PCI of patients with previous stroke. J Thromb Thrombolysis. 2005 Jun; 19(3):147-53. PMID: 16082601.
      View in: PubMed
    73. Upadhya B, Sane DC, Applegate RJ, Kutcher MA, Gandhi SK, Deliargyris EN. Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous coronary intervention. J Invasive Cardiol. 2005 May; 17(5):243-7. PMID: 15879602.
      View in: PubMed
    74. Exaire JE, Tcheng JE, Kereiakes DJ, Kleiman NS, Applegate RJ, Moliterno DJ. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. Catheter Cardiovasc Interv. 2005 Mar; 64(3):369-72. PMID: 15736260.
      View in: PubMed
    75. Deliargyris EN, Upadhya B, Applegate RJ, Kutcher MA, Gandhi SK, Sane DC. Superior in-hospital and 30-day outcomes with abciximab versus eptifibatide: a contemporary analysis of 495 consecutive percutaneous coronary interventions. J Invasive Cardiol. 2004 Nov; 16(11):611-6. PMID: 15550727.
      View in: PubMed
    76. Moliterno DJ, Hermiller JB, Kereiakes DJ, Yow E, Applegate RJ, Braden GA, Dippel EJ, Furman MI, Grines CL, Kleiman NS, Levine GN, Mann T, Nair RN, Stine RA, Yacubov SJ, Tcheng JE. A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. J Am Coll Cardiol. 2003 Sep 17; 42(6):1132-9. PMID: 13678943.
      View in: PubMed
    77. Applegate RJ, Rankin KM, Little WC, Kahl FR, Kutcher MA. Restick following initial Angioseal use. Catheter Cardiovasc Interv. 2003 Feb; 58(2):181-4. PMID: 12552540.
      View in: PubMed
    78. Saw J, Kereiakes DJ, Mahaffey KW, Applegate RJ, Braden GA, Brent BN, Brodie BR, Groce JB, Levine GN, Leya F, Moliterno DJ. Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels. Thromb Res. 2003; 112(5-6):301-6. PMID: 15041274.
      View in: PubMed
    79. Applegate RJ, Grabarczyk MA, Little WC, Craven T, Walkup M, Kahl FR, Braden GA, Rankin KM, Kutcher MA. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002 Jul 03; 40(1):78-83. PMID: 12103259.
      View in: PubMed
    Applegate's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _